RATE OF TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION FROM MOTHER TO CHILD AND SHORT-TERM OUTCOME OF NEONATAL INFECTION - RESULTS OF A PROSPECTIVE COHORT STUDY

被引:85
作者
ANDIMAN, WA
SIMPSON, J
OLSON, B
DEMBER, L
SILVA, TJ
MILLER, G
机构
[1] YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,NEW HAVEN,CT 06510
[2] YALE NEW HAVEN MED CTR,DEPT NURSING,NEW HAVEN,CT 06504
来源
AMERICAN JOURNAL OF DISEASES OF CHILDREN | 1990年 / 144卷 / 07期
关键词
D O I
10.1001/archpedi.1990.02150310026020
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
• In an attempt to determine the rate of transmission of infection from human immunodeficiency virus type 1 (HIV-1) antibody–positive women to their offspring and to describe the short-term outcome of perinatal infection, we enrolled 62 infants in a prospective cohort study during a 30-month period and followed them up for an additional 6 months. The clinical, immunologic, and serologic status of the children was assessed prospectively. Fourteen subjects were symptomatic: 3 had acquired immunodeficiency syndrome, 5 had signs and symptoms that were compatible with HIV-1 infection (Centers for Disease Control, Atlanta, Ga, class P2A), and 6 had ill-defined symptoms that could not be definitely attributed to HIV. Our data indicated that the maximum rate of vertical transmission of HIV-1 infection in New Haven, Conn, was less than 30%, and the rate of HIV-1–associated disease occurring during the first 3 years of life was 16%. The mean and median time to loss of maternal antibody, as detected by Western blot in seroreverters, was approximately 7 months, and the half-life of passive antibody was 38 days. A continued close follow-up of children in the cohort studied, and others like it, is critical to learn the full range of outcomes of HIV infection in the pediatric population. © 1990, American Medical Association. All rights reserved.
引用
收藏
页码:758 / 766
页数:9
相关论文
共 35 条
[1]  
AIUTI F, 1987, LANCET, V2, P858
[2]  
AMADORI A, 1988, LANCET, V1, P852
[3]  
BEASLEY RP, 1983, LANCET, V2, P1099
[4]   A PROSPECTIVE-STUDY OF INFANTS BORN TO WOMEN SEROPOSITIVE FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
BLANCHE, S ;
ROUZIOUX, C ;
MOSCATO, MLG ;
VEBER, F ;
MAYAUX, MJ ;
JACOMET, C ;
TRICOIRE, J ;
DEVILLE, A ;
VIAL, M ;
FIRTION, G ;
DECREPY, A ;
DOUARD, D ;
ROBIN, M ;
COURPOTIN, C ;
CIRARUVIGNERON, N ;
LEDEIST, F ;
GRISCELLI, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (25) :1643-1648
[5]  
BORKOWSKY W, 1987, LANCET, V1, P1168
[6]   OPTIMAL CONDITIONS FOR RECOVERY OF THE HUMAN IMMUNODEFICIENCY VIRUS FROM PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
CASTRO, BA ;
WEISS, CD ;
WIVIOTT, LD ;
LEVY, JA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (11) :2371-2376
[7]  
COWAN MJ, 1984, PEDIATRICS, V73, P382
[8]   DIFFERENCES AMONG HUMAN IMMUNODEFICIENCY VIRUS-STRAINS IN THEIR CAPACITIES TO INDUCE CYTOLYSIS OR PERSISTENT INFECTION OF A LYMPHOBLASTOID CELL-LINE IMMORTALIZED BY EPSTEIN-BARR-VIRUS [J].
DAHL, K ;
MARTIN, K ;
MILLER, G .
JOURNAL OF VIROLOGY, 1987, 61 (05) :1602-1608
[9]  
DAQUILA RT, 1987, YALE J BIOL MED, V60, P545
[10]  
GELFAND HM, 1960, J IMMUNOL, V85, P46